Companies: 10,795·Total market cap: $144.5T
Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc.

KLTONASDAQHealthcare
$0.38
$-0.03(-7.10%)
Market Cap$20079881
P/E Ratio
52W High$3.91
52W Low$0.114
Overview

Klotho Neurosciences, Inc. (KLTO) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · KLTO · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Klotho Neurosciences, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

KLTO insider buying and selling by quarter

KLTO insider selling · KLTO insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
6.4M3.2M0
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · KLTO ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

KLTO executive sell shares · KLTO board member insider trading · KLTO insider trading SEC filing

Showing 14 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

LeBlanc Jeff

CFO

Award

Date

Mar 4

Shares

2,500,000

Price

Value

View Form 4 on SEC.gov

El-Dada Riad Hussein

Director

Award

Date

Mar 4

Shares

350,000

Price

Value

View Form 4 on SEC.gov

ZENTMAN SAMUEL M

Director

Award

Date

Mar 4

Shares

350,000

Price

Value

View Form 4 on SEC.gov

Hirschman Shalom

Director

Award

Date

Mar 4

Shares

350,000

Price

Value

View Form 4 on SEC.gov

McGarity Jon

Director

Award

Date

Mar 4

Shares

350,000

Price

Value

View Form 4 on SEC.gov

SINKULE JOSEPH

CEO · Director

Award

Date

Mar 4

Shares

2,500,000

Price

Value

View Form 4 on SEC.gov

SINKULE JOSEPH

CEO · Director

Other

Date

Sep 25

Shares

400,000

Price

Value

View Form 4 on SEC.gov

LeBlanc Jeff

CFO

Award

Date

Aug 25

Shares

200,000

Price

Value

View Form 4 on SEC.gov

Hirschman Shalom

Director

Award

Date

Aug 5

Shares

70,149

Price

Value

View Form 4 on SEC.gov

SINKULE JOSEPH

CEO · Director

Award

Date

Aug 5

Shares

537,180

Price

Value

View Form 4 on SEC.gov

SINKULE JOSEPH

CEO · Director

Other

Date

Jul 22

Shares

2,000,000

Price

Value

View Form 4 on SEC.gov

McGarity Jon

Director

Award

Date

Aug 5

Shares

14,641

Price

Value

View Form 4 on SEC.gov

ZENTMAN SAMUEL M

Director

Award

Date

Aug 5

Shares

153,494

Price

Value

View Form 4 on SEC.gov

LeBlanc Jeff

CFO

Award

Date

Aug 5

Shares

156,199

Price

Value

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About KLTO insider trading

KLTO insider trades

Klotho Neurosciences, Inc. (KLTO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including SINKULE JOSEPH (CEO · Director), LeBlanc Jeff (CFO), ZENTMAN SAMUEL M (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. KLTO insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Klotho Neurosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

KLTO insider trading · 5 questions

The insiders of Klotho Neurosciences, Inc. (KLTO) include executives and directors such as SINKULE JOSEPH (CEO · Director), LeBlanc Jeff (CFO), ZENTMAN SAMUEL M (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

KLTO board member insider tradingwho are KLTO insidersKLTO insider rosterKlotho Neurosciences, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026